AIM2 and long COVID-19: In a study among PASC patients with lung fibrosis, activation of the Absent in Melanoma 2 (AIM2) inflammasome was associated with the release of IL-1α, IFN-α and TGF-β, a finding not seen in non-PASC patients (306).